Russell Investments Group Ltd. Has $15.87 Million Position in Teleflex Incorporated (NYSE:TFX)

Russell Investments Group Ltd. boosted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 116.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 89,194 shares of the medical technology company's stock after buying an additional 48,064 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.19% of Teleflex worth $15,870,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of TFX. Headlands Technologies LLC bought a new stake in shares of Teleflex during the 4th quarter worth $29,000. Avior Wealth Management LLC grew its holdings in Teleflex by 81.2% in the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after buying an additional 125 shares during the last quarter. IFP Advisors Inc grew its position in Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after acquiring an additional 217 shares during the last quarter. Exchange Traded Concepts LLC boosted its stake in Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after purchasing an additional 94 shares in the last quarter. Finally, R Squared Ltd bought a new position in shares of Teleflex in the fourth quarter valued at about $64,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Price Performance

Teleflex stock traded down $2.47 during trading hours on Tuesday, reaching $129.63. 69,458 shares of the stock were exchanged, compared to its average volume of 615,112. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a twelve month low of $124.66 and a twelve month high of $249.91. The company has a market cap of $6.01 billion, a P/E ratio of 25.82, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The stock has a 50 day moving average of $147.12 and a two-hundred day moving average of $180.28.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to analysts' expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were given a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Royal Bank of Canada cut shares of Teleflex from an "outperform" rating to a "sector perform" rating and dropped their price objective for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. StockNews.com lowered Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Citizens Jmp downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Finally, Raymond James cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $181.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.